NCT06179004View on ClinicalTrials.gov

Supraclavicular Bupivacaine Vs. Supraclavicular Liposomal Bupivacaine for Orthopedic Wrist Surgery

PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Distal Radius FracturesWrist Fractures
Interventions
DRUG

Liposomal bupivacaine

133mg Liposomal bupivacaine plus 10mL 0.5% bupivacaine administered in a supraclavicular single shot perineural injection

DRUG

Bupivacaine Hydrochloride

20mL 0.25% bupivacaine administered in a supraclavicular single shot perineural injection

Trial Locations (1)

27514

RECRUITING

UNC Chapel Hill, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER